Related Experiment Videos

Early identification and referral of liver disease

Sarah Tizzard1, Mark Davenport

  • 1King's College Hospital, London.

Community Practitioner : the Journal of the Community Practitioners' & Health Visitors' Association
|September 29, 2007
PubMed

Insights

This review covers infant jaundice, focusing on conjugated hyperbilirubinemia and neonatal liver disease signs. It highlights community practitioner roles in early detection using a jaundice protocol and identification algorithm.

Area of Science:

  • Neonatology
  • Pediatric Gastroenterology
  • Public Health

Background:

  • Neonatal jaundice is common, but prolonged or conjugated forms can indicate serious liver disease.
  • Early identification of neonatal liver disease is crucial for timely intervention and improved outcomes.
  • Community practitioners play a vital role in the primary screening of infants for prolonged jaundice.

Purpose of the Study:

  • To review the etiology of jaundice, especially conjugated jaundice in infants.
  • To outline the clinical presentation of neonatal liver disease.
  • To emphasize the importance of community practitioners in identifying prolonged infant jaundice and introduce a diagnostic protocol.

Main Methods:

  • Literature review of causes and clinical signs of neonatal jaundice and liver disease.
  • Discussion of the role of primary care providers in infant jaundice assessment.
  • Introduction of a jaundice protocol and an early identification algorithm for clinical use.

Main Results:

  • Key causes of conjugated jaundice in infants are detailed.
  • Characteristic signs and symptoms of neonatal liver disease are presented.
  • The utility of a structured jaundice protocol and algorithm for early detection is proposed.

Conclusions:

  • Prompt recognition of prolonged jaundice in infants by community practitioners is essential.
  • Implementing a standardized jaundice protocol can improve the early diagnosis of neonatal liver disease.
  • Early identification and management strategies are critical for better infant health outcomes.

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not related to...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Esophageal Varices-II: Clinical Features and Management01:28

Esophageal Varices-II: Clinical Features and Management

Esophageal varices often manifest as gastrointestinal bleeding episodes, presenting symptoms like hematemesis (vomiting of blood), hematochezia (passing fresh blood via the rectum), and melena (black, tarry stools). Other signs can include weight loss, anorexia, abdominal discomfort, jaundice, pruritus, altered mental status, and muscle cramps.
In the initial assessment, a thorough review of the patient's medical history is vital to identify risk factors such as liver disease, alcohol abuse, or...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...